Phase II clinical trial of recombinant alpha-2 interferon for biopsy-proven metastatic or recurrent renal carcinoma.

Rosenthal, M A

Phase II clinical trial of recombinant alpha-2 interferon for biopsy-proven metastatic or recurrent renal carcinoma. [electronic resource] - British journal of urology May 1992 - 491-4 p. digital

Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't

0007-1331

10.1111/j.1464-410x.1992.tb15594.x doi


Adult
Drug Evaluation
Female
Humans
Interferon Type I--adverse effects
Kidney Neoplasms--secondary
Male
Middle Aged
Neoplasm Recurrence, Local--therapy
Recombinant Proteins
Treatment Outcome